Literature DB >> 1775159

Pathogenic and nonpathogenic Entamoeba histolytica: identification and molecular cloning of an iron-containing superoxide dismutase.

E Tannich1, I Bruchhaus, R D Walter, R D Horstmann.   

Abstract

Superoxide dismutase (SOD) activity was determined in the cell lysate of the axenically cultured Entamoeba histolytica isolate HM-1:IMSS. Under anaerobic culture conditions, 18.7 (+/- 4.9) units SOD activity (mg protein)-1 were found. By inhibition studies the activity was attributed to an iron-containing type of SOD (FeSOD). Using degenerate oligonucleotide primers derived from regions highly conserved in prokaryotic FeSOD sequences, a genomic DNA fragment was amplified by the polymerase chain reaction. The fragment was used to isolate FeSOD specific cDNA clones from a pathogenic and a nonpathogenic E. histolytica isolate. A comparison of the 2 sequences revealed 5% nucleotide differences resulting in a single amino acid exchange. The primary structure showed the characteristics of an iron-containing type of SOD with a homology of approximately 55% with other FeSOD sequences. The enzyme was found to be encoded by single copy genes in both the pathogenic and the nonpathogenic E. histolytica, but restriction fragment lengths differed between the 2 groups. In 5 isolates studied, no correlation was found between pathogenic behavior of the amebae and the expression of FeSOD-related mRNA.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775159     DOI: 10.1016/0166-6851(91)90130-x

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  22 in total

1.  Identification of a developmentally regulated iron superoxide dismutase of Trypanosoma brucei.

Authors:  M Kabiri; D Steverding
Journal:  Biochem J       Date:  2001-11-15       Impact factor: 3.857

2.  Codon usage in pathogenic Entamoeba histolytica.

Authors:  E Tannich; R D Horstmann
Journal:  J Mol Evol       Date:  1992-03       Impact factor: 2.395

Review 3.  Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites.

Authors:  Vahab Ali; Tomoyoshi Nozaki
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

4.  Reduction of cell surface glycosylphosphatidylinositol conjugates in Entamoeba histolytica by antisense blocking of E. histolytica GlcNAc-phosphatidylinositol deacetylase expression: effect on cell proliferation, endocytosis, and adhesion to target cells.

Authors:  Divya Vats; Ram A Vishwakarma; Sudha Bhattacharya; Alok Bhattacharya
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 5.  Archaea and the prokaryote-to-eukaryote transition.

Authors:  J R Brown; W F Doolittle
Journal:  Microbiol Mol Biol Rev       Date:  1997-12       Impact factor: 11.056

Review 6.  Progress towards development of a vaccine for amebiasis.

Authors:  S L Stanley
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

7.  Removal of hydrogen peroxide by the 29 kDa protein of Entamoeba histolytica.

Authors:  I Bruchhaus; S Richter; E Tannich
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 8.  Superoxide dismutases and superoxide reductases.

Authors:  Yuewei Sheng; Isabel A Abreu; Diane E Cabelli; Michael J Maroney; Anne-Frances Miller; Miguel Teixeira; Joan Selverstone Valentine
Journal:  Chem Rev       Date:  2014-04-01       Impact factor: 60.622

9.  Escherichia coli iron superoxide dismutase targeted to the mitochondria of yeast cells protects the cells against oxidative stress.

Authors:  R Balzan; W H Bannister; G J Hunter; J V Bannister
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Pyrophosphate-dependent phosphofructokinase of Entamoeba histolytica: molecular cloning, recombinant expression and inhibition by pyrophosphate analogues.

Authors:  I Bruchhaus; T Jacobs; M Denart; E Tannich
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.